Voclosporin

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 149 publications

The role of monoclonal antibodies in the treatment of lupus nephritis.

The role of monoclonal antibodies in the treatment of lupus nephritis.

Journal: Expert opinion on biological therapy

Published: April 07, 2026

Obinutuzumab (Gazyva) for lupus nephritis.

Obinutuzumab (Gazyva) for lupus nephritis.

Journal: The Medical letter on drugs and therapeutics

Published: March 07, 2026

High-Dose Voclosporin Protects Against Acute Kidney Injury via Regnase-2-Mediated NGAL MRNA Decay.

High-Dose Voclosporin Protects Against Acute Kidney Injury via Regnase-2-Mediated NGAL MRNA Decay.

Journal: International journal of molecular sciences

Published: March 04, 2026

Single-center experience of voclosporin use for pediatric lupus nephritis: a case series.

Single-center experience of voclosporin use for pediatric lupus nephritis: a case series.

Journal: Rheumatology (Oxford, England)

Published: February 27, 2026

Recent advances in immunosuppressive therapy for lupus nephritis.

Recent advances in immunosuppressive therapy for lupus nephritis.

Journal: Immunological medicine

Published: January 07, 2026

Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis.

Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis.

Journal: Frontiers in medicine

Published: November 20, 2025

Refractory Lupus Nephritis in a Woman With Systemic Lupus Erythematosus on Immunosuppressive Therapy: A Case Report.

Refractory Lupus Nephritis in a Woman With Systemic Lupus Erythematosus on Immunosuppressive Therapy: A Case Report.

Journal: Cureus

Published: November 07, 2025

Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement.

Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement.

Journal: Reumatismo

Published: October 24, 2025

Safety assessment of voclosporin: a real-world disproportionality analysis of the FAERS database.

Safety assessment of voclosporin: a real-world disproportionality analysis of the FAERS database.

Journal: Immunopharmacology and immunotoxicology

Published: October 16, 2025

Systemic Lupus Erythematosus: Ophthalmological Safety Considerations of Emerging and Conventional Therapeutic Agents.

Systemic Lupus Erythematosus: Ophthalmological Safety Considerations of Emerging and Conventional Therapeutic Agents.

Journal: International journal of molecular sciences

Published: October 07, 2025

Response: Does baseline nephrotic range proteinuria determine the long-term outcomes of membranous lupus nephritis patients? Reply Letter to Capuano et al. (Letter to the Editor: Voclosporin in Late Onset Lupus Nephritis with Anti-PLA2R Antibodies).

Response: Does baseline nephrotic range proteinuria determine the long-term outcomes of membranous lupus nephritis patients? Reply Letter to Capuano et al. (Letter to the Editor: Voclosporin in Late Onset Lupus Nephritis with Anti-PLA2R Antibodies).

Journal: Seminars in arthritis and rheumatism

Published: September 10, 2025

Refractory Lupus Podocytopathy: The Role of Repeat Biopsy and Rituximab.

Refractory Lupus Podocytopathy: The Role of Repeat Biopsy and Rituximab.

Journal: Cureus

Published: September 08, 2025

Showing 1-12 of 149

Last Updated: 04/28/2026